Kerry R. Hicks
Director · TriSalus Life Sciences, Inc.
Individual
- 2025
- May 15, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kerry R. Hicks files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael P. Stansky - $3.01M in TLSI purchases and sales in the last 12 months
- Mary T. Szela - $307K in TLSI purchases and sales in the last 12 months
- Mats Wahlstrom - $152K in TLSI purchases and sales in the last 12 months
- William Valle - $125K in TLSI purchases and sales in the last 12 months
- Gary B. Gordon - $65K in TLSI purchases and sales in the last 12 months
- David Patience - $32K in TLSI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kerry R. Hicks?
Kerry R. Hicks is a corporate insider, tracked as Director of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kerry R. Hicks last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 2 filings going back to 2025.
